Bradley Subject of Informal SEC Probe

Drugmaker Bradley Pharmaceuticals Inc. reported Monday that the Securities and Exchange Commission launched an informal probe to determine if the company violated securities laws. The SEC requested certain information and documents regarding revenue recognition and capitalization of certain payments, the company said. Bradley said the SEC originally alerted the company of the probe in December but stated that the investigation was "confidential and nonpublic," and that it should not be construed that any violation had occurred.

ABC News (http://abcnews.go.com/Business/wireStory?id=538039&CMP=OTC-RSSFeeds0312)